Galmed Pharmaceuticals Cash from Investing (TTM) Trends

Galmed Pharmaceuticals Ltd (GLMD)

0.3684 +0.01 (+3.98%) USD | NASDAQ | Apr 17, 16:00

0.3356 -0.03 (-8.90%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	0.80M
September 30, 2023	0.50M
June 30, 2023	9.16M
March 31, 2023	12.60M
December 31, 2022	17.56M
September 30, 2022	21.97M
June 30, 2022	21.40M
March 31, 2022	19.42M
December 31, 2021	11.46M
September 30, 2021	3.214M
June 30, 2021	14.66M
March 31, 2021	10.98M
December 31, 2020	16.54M
September 30, 2020	20.17M
June 30, 2020	0.555M
March 31, 2020	-6.335M
December 31, 2019	6.678M
September 30, 2019	5.219M
June 30, 2019	30.51M
March 31, 2019	-36.15M
December 31, 2018	-60.02M

Date	Value
September 30, 2018	-47.75M
June 30, 2018	-80.65M
March 31, 2018	-2.93M
December 31, 2017	6.444M
September 30, 2017	-7.246M
June 30, 2017	6.413M
March 31, 2017	6.765M
December 31, 2016	6.336M
September 30, 2016	9.371M
June 30, 2016	6.337M
March 31, 2016	10.04M
December 31, 2015	-11.11M
September 30, 2015	-22.02M
June 30, 2015	-21.43M
March 31, 2015	-28.15M
December 31, 2014	-9.016M
September 30, 2014	-0.02M
June 30, 2014	-0.022M
March 31, 2014	-0.015M
December 31, 2013	0.003M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-6.335M

Minimum

Mar 2020

30.51M

Maximum

Jun 2019

11.42M

Average

11.46M

Median

Dec 2021

Cash from Investing (TTM) Benchmarks